Masimo Corporation - Common Stock (MASI)

Frequently Asked Questions About Masimo Corporation - Common Stock (MASI)

Does Masimo engage in any partnerships?

Yes, Masimo engages in various strategic partnerships and collaborations with healthcare providers, technology companies, and academic institutions to enhance its product offerings and broaden access to its innovative monitoring solutions. These partnerships help in advancing research as well as improving clinical practices.

Does Masimo have any significant competitors?

Yes, Masimo faces competition from several companies within the medical technology and monitoring device sectors, including Medtronic, Philips Healthcare, and GE Healthcare. However, Masimo differentiates itself through its patented non-invasive technologies and a strong focus on innovation.

How can I invest in Masimo Corporation?

Investing in Masimo Corporation can be done through the purchase of shares on the NASDAQ under the ticker symbol MASI. Interested investors should consult with a financial advisor or utilize a brokerage platform to buy stocks and monitor the performance of the company in the market.

How does Masimo contribute to improving patient care?

Masimo contributes to improving patient care by providing advanced monitoring technologies that enhance the accuracy of readings, reduce the need for invasive procedures, and enable earlier detection of potential health issues. This leads to better clinical decisions and improves overall patient outcomes.

How does Masimo's SET technology work?

Masimo's SET technology operates by using advanced algorithms and multi-wavelength light absorption to non-invasively measure arterial oxygen saturation (SpO2). This technology can accurately function in challenging conditions, such as motion, low perfusion, and skin pigmentation, setting it apart from traditional pulse oximeters.

How has Masimo adapted to changes in the healthcare industry?

Masimo has adapted to changes in the healthcare industry by continuously innovating its product offerings, embracing digital health technologies, and enhancing connectivity in monitoring devices. This adaptability has positioned Masimo as a leader in non-invasive monitoring as the industry evolves towards more integrated patient solutions.

Is Masimo Corporation a publicly traded company?

Yes, Masimo Corporation is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol MASI. The company has been publicly traded since its initial public offering (IPO) in 2007.

What are some key products offered by Masimo?

Masimo's key products include the SET pulse oximetry technology, which measures blood oxygen saturation non-invasively, as well as the Root patient monitoring and connectivity platform. The company also offers non-invasive monitors for vital signs, including continuous and spot-check monitoring solutions, such as those for carbon dioxide and hemoglobin levels.

What does Masimo Corporation do?

Masimo Corporation is a global medical technology company that develops innovative non-invasive monitoring technologies, devices, and software. Primarily, it is known for its pulse oximetry technologies that accurately measure blood oxygen levels through the skin, as well as various other patient monitoring solutions that enhance clinical decision-making and improve patient outcomes.

What industries does Masimo serve?

Masimo serves various industries, predominantly the healthcare and medical sectors. Their products are widely used in hospitals, surgical centers, clinics, and even at home, focusing on enhancing patient monitoring and safety for both acute and chronic conditions.

What is Masimo's approach to corporate social responsibility?

Masimo's approach to corporate social responsibility (CSR) emphasizes ethical business practices, community engagement, and environmental stewardship. The company strives to make a positive impact in the healthcare industry and the communities it serves through initiatives that promote health and well-being.

What is Masimo's current market position?

Masimo holds a strong market position as a leader in non-invasive monitoring technology. Its continuous focus on research and development has allowed it to outperform many competitors in various monitoring categories, contributing to sustained growth and visibility in the healthcare technology sector.

What is Masimo's philosophy regarding innovation?

Masimo's philosophy revolves around innovation driven by a commitment to improving patient outcomes. The company invests heavily in research and development to create advanced technologies that address limitations in current monitoring practices, aiming to enhance the efficacy and reliability of patient care.

What is Masimo's vision for the future of patient monitoring?

Masimo's vision for the future of patient monitoring is to leverage advanced technologies, artificial intelligence, and connectivity to create more comprehensive, accurate, and user-friendly monitoring solutions. The goal is to improve patient outcomes globally while reducing healthcare costs and enhancing clinical workflows.

What is the significance of Masimo's rainbow technology?

Masimo's rainbow technology refers to its innovative approach to measuring a variety of blood constituents using non-invasive methods. It allows for the monitoring of not only oxygen saturation but also parameters like hemoglobin levels and carboxyhemoglobin, providing clinicians with a comprehensive view of a patient’s respiratory status.

What markets does Masimo operate in internationally?

Masimo operates in numerous international markets, including Europe, Asia, the Middle East, and Latin America. The company's global presence allows it to serve diverse healthcare systems and adapt its solutions to meet the specific needs of different regions.

What recent advancements has Masimo made?

Recently, Masimo has made advancements in expanding its product line to include additional monitoring capabilities, such as non-invasive monitoring of hemoglobin and carbon dioxide levels, further enhancing the breadth of its patient monitoring solutions and improving patient safety.

What recognition has Masimo received for its technology?

Masimo has received numerous awards and recognitions for its innovative technology and commitment to patient safety. This includes accolades from healthcare organizations and positive evaluations from clinical studies that validate the efficacy and accuracy of its monitoring devices in real-world settings.

When was Masimo Corporation founded?

Masimo Corporation was founded in 1989 by Joe Kiani. Since its inception, the company has focused on advancing non-invasive monitoring technology to enhance patient care and outcomes in hospitals and home care settings.

Where is Masimo Corporation headquartered?

Masimo Corporation is headquartered in Irvine, California. This location serves as the central hub for the company's operations, research and development, and administrative functions.

What is the current price of Masimo Corporation - Common Stock?

The current price of Masimo Corporation - Common Stock is 171.48

When was Masimo Corporation - Common Stock last traded?

The last trade of Masimo Corporation - Common Stock was at 4:00 pm EDT on April 2nd, 2025

What is the market capitalization of Masimo Corporation - Common Stock?

The market capitalization of Masimo Corporation - Common Stock is 9.19B

How many shares of Masimo Corporation - Common Stock are outstanding?

Masimo Corporation - Common Stock has 53.60M shares outstanding.